Serum soluble CD30 levels in Behcet's disease

Basit Öğe Kaydı
dc.contributor.authorDüzgün, N
dc.contributor.authorAyaslioglu, E
dc.contributor.authorTutkak, H
dc.date.accessioned2025-01-21T16:44:22Z
dc.date.available2025-01-21T16:44:22Z
dc.date.issued2004
dc.departmentKırıkkale Üniversitesi
dc.description.abstractBehcet's disease is associated with the inflammatory response. Several reports indicate the presence of primarily CD4+ T cells of the Th1 subtype in the inflammation process of the disease. Serum soluble CD30 (sCD30) is reported to be released from CD4+ Th2 type cells and has been suggested to be a marker of Th2 activity In this study, serum sCD30 levels were measured in active and inactive patients with Behcet's disease, healthy controls and a group of patients with rheumatoid arthritis, typical Th1 disorder using enzyme immunoassay kit. Mean sCD30 value of 54 active patients were found significantly higher than in those of 17 inactive patients (p = 0.027), 20 healthy controls (p = 0.040) and 25 patients with rheumatoid arthritis (p < 0.001). There was a significant correlation between increased sCD30 levels and clinical activity index in active patients with Behcet's disease. High serum levels of sCD30 may reflect the activation of CD4+ T cells or a subset of them in active BD patients. In addition. to serum sCD30 levels, measurements of the Th2 cytokines may be a helpful tool for the evaluation of Th2 activity in Behcet's disease.
dc.identifier.endpageS20
dc.identifier.issn0392-856X
dc.identifier.issn1593-098X
dc.identifier.issue4
dc.identifier.pmid15515777
dc.identifier.startpageS17
dc.identifier.urihttps://hdl.handle.net/20.500.12587/25442
dc.identifier.volume22
dc.identifier.wosWOS:000224479600005
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherClinical & Exper Rheumatology
dc.relation.ispartofClinical and Experimental Rheumatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.subjectsoluble CD30; disease activity; Behcet's disease
dc.titleSerum soluble CD30 levels in Behcet's disease
dc.typeArticle

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu